Rosana F. Marta - Concepedia

Author

Rosana F. Marta

Universidad de Buenos Aires ORCID

Also Known As

R F Marta, R MARTA, R. F. Marta, R.F. MARTA, R.F. Marta, Rodrigo Marta, Rosana F Marta, Rosana F. Marta, Rosana Marta

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Universidad de Buenos Aires Consejo Nacional de Investigaciones Científicas y Técnicas Institute for Medical Research Hospital Ramos Mejía Academia Nacional de Medicina

About

Rosana F. Marta is an author at Universidad de Buenos Aires specializing in hematology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	415
2	Health Sciences	1	1	12
3	Public Health	1	1	26
4	Allergy	1	1	12
5	Biochemistry	1	1	23

Rosana F. Marta

Publications

Citations

H-Index

Page 1

	Year	Citations
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation Paula G. Heller, Ana C. Glembotsky, Manish J. Gandhi, Blood	2005	100
Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms Cecilia P. Marín Oyarzún, Agostina Carestia, Paola R. Lev, Scientific Reports	2016	75
Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. Rosana F. Marta, Verónica S. Montero, C. Erik Hack, American Journal of Tropical Medicine and Hygiene InflammationThrombosisArgentine Hemorrhagic FeverAutoimmune DiseaseAhf Patients	1999	69
Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies Nora P. Goette, Ana C. Glembotsky, Paola R. Lev, PLoS ONE Itp PlasmaApoptosisImmune RegulationImmunologyCell Death	2016	65
Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets Ana C. Glembotsky, Dominique Bluteau, Yesica R. Espasandin, Journal of Thrombosis and Haemostasis Hematological MalignancyBlood PlateletMedicineGeneticsPlatelet Function Defect	2014	62
<i>JAK2</i>V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status Paula G. Heller, Paola R. Lev, Juan P. Salim, European Journal Of Haematology	2006	60
Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia Cecilia P. Marín Oyarzún, Ana C. Glembotsky, Nora P. Goette, Frontiers in Immunology	2020	59
Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count Paola R. Lev, Matías Grodzielski, Nora P. Goette, British Journal of Haematology	2014	51
Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia Matías Grodzielski, Nora P. Goette, Ana C. Glembotsky, Scientific Reports	2019	46
Early Markers of Blood Coagulation and Fibrinolysis Activation in Argentine Hemorrhagic Fever María V. Heller, Rosana F. Marta, A. Sturk, Thrombosis and Haemostasis ImmunologyPathologyThrombin-antithrombin ComplexesThrombosisHematology	1995	44

Page 1